Nutrigenomic Studies on the Ameliorative Effect of Enzyme-Digested Phycocyanin in Alzheimer’s Disease Model Mice
1
Health Care Technical G., Chiba Plants, DIC Corporation, Ichihara 290-8585, Chiba, Japan
2
R&D Institute, Intelligence & Technology Lab, Inc., Kaizu 503-0628, Gifu, Japan
3
Biomedical Institute, NPO Primate Agora, Kaizu 503-0628, Gifu, Japan
*
Author to whom correspondence should be addressed.
Academic Editor: Marilyn Cornelis
Nutrients 2021, 13(12), 4431; https://doi.org/10.3390/nu13124431
Received: 5 November 2021
/
Revised: 3 December 2021
/
Accepted: 6 December 2021
/
Published: 10 December 2021
(This article belongs to the Section Nutrigenetics and Nutrigenomics)
Alzheimer’s disease (AD) is the most common form of dementia, and the cognitive impairments associated with this degenerative disease seriously affect daily life. Nutraceuticals for the prevention or delay of AD are urgently needed. It has been increasingly observed that phycocyanin (PC) exerts neuroprotective effects. AD model mice intracerebroventricularly injected with amyloid beta-peptide 25–35 (Aβ25–35) at 10 nmol/head displayed significant cognitive impairment in the spontaneous alternation test. Cognitive impairment was significantly ameliorated in mice treated with 750 mg/kg of enzyme-digested (ED) PC by daily oral administration for 22 consecutive days. Application of DNA microarray data on hippocampal gene expression to nutrigenomics studies revealed that oral EDPC counteracted the aberrant expression of 35 genes, including Prnp, Cct4, Vegfd (Figf), Map9 (Mtap9), Pik3cg, Zfand5, Endog, and Hbq1a. These results suggest that oral administration of EDPC ameliorated cognitive impairment in AD model mice by maintaining and/or restoring normal gene expression patterns in the hippocampus.
View Full-Text
Keywords:
Y maze; Spirulina; Creutzfeldt–Jakob disease; neurodegenerative disease; hippocampus; amyloid β-peptide(25–35)
▼
Show Figures
Figure 1
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Imai, Y.; Koseki, Y.; Hirano, M.; Nakamura, S. Nutrigenomic Studies on the Ameliorative Effect of Enzyme-Digested Phycocyanin in Alzheimer’s Disease Model Mice. Nutrients 2021, 13, 4431. https://doi.org/10.3390/nu13124431
AMA Style
Imai Y, Koseki Y, Hirano M, Nakamura S. Nutrigenomic Studies on the Ameliorative Effect of Enzyme-Digested Phycocyanin in Alzheimer’s Disease Model Mice. Nutrients. 2021; 13(12):4431. https://doi.org/10.3390/nu13124431
Chicago/Turabian StyleImai, Yasuyuki, Yurino Koseki, Makoto Hirano, and Shin Nakamura. 2021. "Nutrigenomic Studies on the Ameliorative Effect of Enzyme-Digested Phycocyanin in Alzheimer’s Disease Model Mice" Nutrients 13, no. 12: 4431. https://doi.org/10.3390/nu13124431
Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
